Showing results (551-560 of 3,148) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|April 4, 2020
Long-term clinically relevant rodent model of methotrexate-induced cognitive impairmentConnor Berlin, Katharine Lange, H Carl Lekaye, et al.Neuro-Oncology|April 1, 2020
Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastomaJessica T Taylor, Stuart Ellison, Alina Pandele, et al.Neuro-Oncology|October 23, 2020
Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: longitudinal assessment by F-DOPA PETFrancesco Cicone, Luciano Carideo, Claudia Scaringi, et al.Neuro-Oncology|October 13, 2020
Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomasMarco Rossi, Lorenzo Gay, Federico Ambrogi, et al.Neuro-Oncology|October 20, 2020
Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic gliomaNicole M Brossier, Sharanya Thondapu, Olivia M Cobb, et al.Neuro-Oncology|January 10, 2019
Using germline variants to estimate glioma and subtype risksJeanette E Eckel-Passow, Paul A Decker, Matt L Kosel, et al.Neuro-Oncology|November 26, 2019
ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastomaMaren Cam, Manish Charan, Alessandra M Welker, et al.Neuro-Oncology|December 18, 2019
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)Timothy F Cloughesy, Andrew Brenner, John F de Groot, et al.Neuro-Oncology|October 30, 2020
Brain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography studyAurelija Jucaite, Per Stenkrona, Zsolt Cselényi, et al.Neuro-Oncology|February 17, 2018
Temozolomide-associated hypermutation in gliomasSerah Choi, Yao Yu, Matthew R Grimmer, et al.Pageof 315